For Immediate Release
Office of the Press Secretary
June 26, 2004
Fact Sheet: U.S.-EU Summit: Fighting the Challenge of the HIV/AIDS Epidemic
"HIV/AIDS is one of the greatest medical challenges of our time.
The disease has killed more than 20 million people. Today, 42 million
more are living with HIV."
President George W. Bush
May 27, 2003
In recognition of the extent of the crisis and of our joint
commitment to fighting HIV/AIDS and other communicable diseases, we are
determined to further strengthen cooperation between the European Union
and the United States. Today, the United States and the European Union
reaffirmed their commitment to combat AIDS, pledging to:
Support the U.N. Declaration of Commitment on HIV/AIDS; Ensure
resources from the Global Fund for AIDS, Malaria, and Tuberculosis
are available to countries most severely affected by the disease;
Cooperate on formally amending WTO rules in accordance with our
groundbreaking agreement on intellectual property rights and public
health;
Support and accelerate the development of vaccines and
technologies to prevent the spread of HIV/AIDS and other
communicable diseases; and
Work to promote donor coordination and civil society and private
involvement in the fight against AIDS.
President Bush is leading a global effort to combat the HIV/AIDS
pandemic through his historic $15 billion Emergency Plan for AIDS
Relief and his commitment to the Global Fund to Fight AIDS,
Tuberculosis, and Malaria, to which the United States has pledged more
than $1.96 billion, or 36 percent of all pledges through 2008.
On June 10, 2004, President Bush and his G-8 counterparts endorsed
the establishment of a Global HIV Vaccine Enterprise, a virtual
consortium to accelerate HIV vaccine development by enhancing
coordination, information sharing, and collaboration globally.
President Bush announced plans to establish a new U.S. Vaccine
Research & Development Center, in addition to the one at the United
States National Institutes of Health. The new center will become a key
component of the Global HIV Vaccine Enterprise. The United States is
investing $488 million in HIV vaccine development in FY2004, and has
requested $533 million in FY2005.
# # #
|